检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:李元杰[1,2] 张蕾[1] 隋御[1] 徐方[1,2]
机构地区:[1]宁夏医科大学基础医学院,宁夏银川750004 [2]宁夏医科大学生育力保持教育部重点实验室,宁夏银川750004
出 处:《基础医学与临床》2014年第12期1623-1628,共6页Basic and Clinical Medicine
基 金:国家自然科学基金(31360251);宁夏自然科学基金(NZ13079)
摘 要:目的探讨沉默REV3和MMS2逆转结肠癌耐药细胞系THC8307/L-OHP细胞对奥沙利铂(L-OHP)的耐药性。方法 THC8307/L-OHP细胞转染含microRNA片段重组质粒后,用实时荧光定量PCR法(qRT-PCR)和免疫荧光法检测目的基因表达,选择低表达效率具有统计学意义的细胞作为实验组细胞。分别应用MTT法、罗丹明123实验、流式细胞术检测细胞对L-OHP药物敏感度和细胞凋亡。结果与对照组相比,L-OHP对实验组细胞的半数抑制浓度(IC50)及耐药指数(RI)减低(P<0.05),实验组细胞经L-OHP处理后凋亡率显著增高(P<0.05),实验组细胞MMS2和REV3蛋白表达水平降低(P<0.05)。结论下调REV3和MMS2在逆转人结肠癌细胞对L-OHP的耐药性和促进肿瘤细胞的凋亡上有一定作用。Objective To explore the effect of silencing REV3 and MMS2 gene in reversing oxaliplatin (L-OHP) resistance of human colon carcinoma THC8307/L-OHP cell line. Methods The real-time fluorescent quantitative PCR (qRT-PCR) was used to detect MMS2 expression in L-OHP-resistant THC8307/L-OHP cells and THC8307/L-OHP cells transfected with MMS2/REV3-RNAi plasmid recto or empty plasmid vector. The difference in MMS2 and REV3 expression was compared. MrlT assay, Rhodamine 123 assay and Flow-cytometric analysis were used to detect transfection of THC8307/L-OHP cells to L-OHP drug sensitivity, apoptosis on treatment with L-OHP. The protein expression of MMS2 and REV3 in THC8307/L-OHP cells was detected by immunofluoreseence. Results Compared to the control group, IC50 and resistance index(RI) of L-OHP in experimental group cells was lower ( P 〈 0.05 ) , apoptosis on treatment with L-OHP increased ( P 〈 0.05 ). Furthermore, the protein expression of MMS2 and REV3 was downregulated in experimental group cells ( P 〈 0.05 ). Conclu- sions Silencing REV3 and MMS2 gene from Oxaliplatin-resistant human colon cancer cells enhances the drug- sensitivity to L-OHP and induces apoptosis.
关 键 词:RNA干扰 MMS2 REV3 THC8307/L-OHP细胞 细胞凋亡
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222